Business Valuation

Initial Public Offering (IPO)

Congratulations to Kintor Pharmaceutical Ltd. (stock code: 9939.HK) on its successful listing on the main board of HKSE on 22 May 2020. With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services relating to equity financing, equity incentive plan, intangible assets impairment test and acquisitions.
 
<img src="../../../../../uploads/Kintor_eng_363a47d49a.jpeg" width="700" />

Congratulations to Kintor Pharmaceutical Ltd. (Stock Code: 9939.HK) on its Successful Listing 

With nearly 10 years of experience in valuation sector. Irene has led several local and overseas valuation and advisory projects across different industries for transaction, IPO and financial reporting purposes.
 
In her new role, Irene will continue her leadership and leverage her extensive expertise on valuation advisory services to bring value to AVISTA’s next-level growth.
 
<img src="../../../../../uploads/Irene_EN_61f9e21e02.png" width="500" />

adventure-1840310_1920

Congratulations to Ms. Irene Ma, who has been promoted to Associate Director of Valuation Advisory team in AVISTA Shanghai.

AVISTA Group was honored to be invited by Hong Kong Cyberport Management Company Limited (“Cyberport”) for 4 consecutive years to participate in the Cyberport Venture Capital Forum 2024, themed “Innovation Challenger: Building New Venture Visions”. Our Managing Partner, Mr. Vincent Pang, and our Principal of Risk Management Advisory, Ms. Sabrina Lam, had the privilege of conducting one-on-one ESG consultations with start-up companies who are members of the Cyberport Professional Service Network (CPN) in the Start-up Clinic session. The forum took place successfully on October 24-25 at Cyberport.
 
During these consultation sessions, Mr. Pang and Ms. Lam engaged in in-depth discussions with start-ups in the greentech, e-commerce and online education industries on the essential elements of effective governance and sustainability. The discussions centred around the implementation of ESG practices and the unlocking of investment value through sound governance and sustainability strategies. The consultations also highlighted the significance of sustainability reporting and compliance, offering valuable insights to assist start-ups in enhancing their business development.
 
At AVISTA Group, we understand the challenges and uncertainties that entrepreneurs encounter on their journey to success. We are committed to cultivating a collaborative and supportive environment where start-ups can flourish and realize their full potential. Our goal is to provide the necessary guidance and expertise to navigate the complexities of the business landscape and uncover opportunities for sustainable growth.
 
<img src="../../../../../uploads/Image_52_95f4e336e3.jpeg" width="500" /> <img src="../../../../../uploads/Image_53_e367968dcc.jpeg" width="500" />
<img src="../../../../../uploads/Image_54_58a6560d17.jpeg" width="500" /> <img src="../../../../../uploads/Image_50_bb338e2ee8.jpeg" width="500" /> <img src="../../../../../uploads/Image_49_58ebcb51e6.jpeg" width="500" />

Image (49).jpeg

As the ESG consultant in the Start-up Clinic at the Cyberport Venture Capital Forum 2024 (CVCF)

Congratulations to WeRide Inc. (WRD.US) on its successful Listing on NASDAQ on 25 October 2024
 
WeRide Inc. is a leading, commercial-stage, global company that develops autonomous driving technologies from Level 2 to Level 4. WeRide aims to develop safe and reliable driverless solutions to make mobility and transportation safer, more affordable, and accessible.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on preferred stocks, esop, IPs.
 
Congratulations again to WeRide Inc. (WRD.US) on its successful listing. The issue price is USD 15.50 per share, and the amount of funds raised is USD 100 million.
 
<img src="../../../../../uploads/Slide1_5a78b67192.png" width="500" />